Your browser doesn't support javascript.
loading
First international consensus on the diagnosis and management of fibromuscular dysplasia.
Gornik, Heather L; Persu, Alexandre; Adlam, David; Aparicio, Lucas S; Azizi, Michel; Boulanger, Marion; Bruno, Rosa M; De Leeuw, Peter; Fendrikova-Mahlay, Natalia; Froehlich, James; Ganesh, Santhi K; Gray, Bruce H; Jamison, Cathlin; Januszewicz, Andrzej; Jeunemaitre, Xavier; Kadian-Dodov, Daniella; Kim, Esther S H; Kovacic, Jason C; Mace, Pamela; Morganti, Alberto; Sharma, Aditya; Southerland, Andrew M; Touzé, Emmanuel; Van der Niepen, Patricia; Wang, Jiguang; Weinberg, Ido; Wilson, Scott; Olin, Jeffrey W; Plouin, Pierre-Francois.
Afiliación
  • Gornik HL; Division of Cardiovascular Medicine, Department of Cardiovascular Medicine, University Hospitals Cleveland Medical Center and UH Harrington Heart and Vascular Institute, Cleveland, Ohio, USA.
  • Persu A; Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
  • Adlam D; Department of Cardiovascular Sciences.
  • Aparicio LS; NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
  • Azizi M; Hypertension Section, Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Boulanger M; Paris Descartes University.
  • Bruno RM; Hypertension Unit, Assistance-Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou.
  • De Leeuw P; Institut National de la Santé et de la Recherche Médicale, Centre d'Investigation Clinique 1418, Paris.
  • Fendrikova-Mahlay N; Normandie Université, UNICAEN, Inserm U1237, CHU Caen Normandie, Caen, France.
  • Froehlich J; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Ganesh SK; Department of Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Gray BH; Division of Cardiovascular Medicine, Department of Cardiovascular Medicine, University Hospitals Cleveland Medical Center and UH Harrington Heart and Vascular Institute, Cleveland, Ohio, USA.
  • Jamison C; Frankel Cardiovascular Center, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
  • Januszewicz A; Frankel Cardiovascular Center, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
  • Jeunemaitre X; University of South Carolina School of Medicine Greenville, Greenville, South Carolina, USA.
  • Kadian-Dodov D; Association Belge De Patients Atteints De Dysplasie Fibromusculaire/FMD Groep België (FMD-Be), Brussels, Belgium.
  • Kim ESH; Department of Hypertension, Institute of Cardiology, Warsaw, Poland.
  • Kovacic JC; APHP, Department of Genetics and Centre for Rare Vascular Diseases, Hôpital Européen Georges Pompidou.
  • Mace P; INSERM, U970 - PARCC, University Paris Descartes, Sorbonne Paris Cité, Paris, France.
  • Morganti A; Zena and Michael A. Wiener Cardiovascular Institute and Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai, New York.
  • Sharma A; Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Southerland AM; Zena and Michael A. Wiener Cardiovascular Institute and Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Icahn School of Medicine at Mount Sinai, New York.
  • Touzé E; Fibromuscular Dysplasia Society of America (FMDSA), North Olmsted, Ohio, USA.
  • Van der Niepen P; Centro Fisiologia Clinica e Ipertensione, Policlinico Hospital, University of Milan, Milan, Italy.
  • Wang J; Cardiovascular Medicine Division, Department of Medicine.
  • Weinberg I; Department of Neurology, University of Virginia, Charlottesville, Virginia, USA.
  • Wilson S; Normandie Université, UNICAEN, Inserm U1237, CHU Caen Normandie, Caen, France.
  • Olin JW; Department of Nephrology and Hypertension, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
  • Plouin PF; Shanghai Institute of Hypertension and Center for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
J Hypertens ; 37(2): 229-252, 2019 02.
Article en En | MEDLINE | ID: mdl-30640867
ABSTRACT
This article is a comprehensive document on the diagnosis and management of fibromuscular dysplasia (FMD) which was commissioned by the Working Group 'Hypertension and the Kidney' of the European Society of Hypertension (ESH) and the Society for Vascular Medicine (SVM). This document updates previous consensus documents/scientific statements on FMD published in 2014 with full harmonization of the position of European and US experts. In addition to practical consensus-based clinical recommendations, including a consensus protocol for catheter-based angiography and percutaneous angioplasty for renal FMD, the document also includes the first analysis of the European/International FMD Registry and provides updated data from the US Registry for FMD. Finally, it provides insights on ongoing research programs and proposes future research directions for understanding this multifaceted arterial disease.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistema de Registros / Displasia Fibromuscular Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline Límite: Humans Idioma: En Revista: J Hypertens Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistema de Registros / Displasia Fibromuscular Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline Límite: Humans Idioma: En Revista: J Hypertens Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos